The medtech value challenge

Start adding items to your reading lists:
Save this item to:
This item has been saved to your reading list.


The medical technology industry has enjoyed a period of exceptional performance over the last five years. Despite concerns about rising healthcare costs and the struggle for medtech companies to develop innovative new products and services, CEOs and investors remain optimistic about the prospects for the industry. In the attached paper, we will examine the factors driving the recent performance of the industry and how medtech can continue to drive value.

Contact us

James Woods

Principal, Deals, PwC US

Allison Lockberg

Manager, US Deals, PwC US

Follow us